Decoding Your Health: Mapmygenome and Apollo Clinic Announce Strategic Genomics Tie-Up
In a major step forward for personalized healthcare, diagnostics pioneer Mapmygenome has teamed up with Apollo Clinic to roll out DNA-based risk and immunity mapping.
By combining Mapmygenome’s leading-edge genomic research with Apollo Clinic’s trusted clinical network, this partnership makes predictive, personalized medicine highly accessible to everyday patients looking to understand their unique health profile.
Bridging Clinical Expertise and DNA Insights
The collaboration leverages genomic testing to move healthcare from reactive treatment to proactive prevention. Through Apollo Clinic's extensive footprint, patients can now access specialized DNA screening designed to:
-
Map Personal Health Risks: Understand how your genetic makeup influences your immune response and predisposition to severe health conditions.
-
Customize Preventive Plans: Use genetic markers to help clinicians build highly individualized lifestyle and treatment roadmaps.
-
Target Treatment Efficacy: Check specific biomarkers that indicate how your body reacts to common medications, maximizing treatment benefits while minimizing adverse toxicity.
Bringing the 'Health Horoscope' to Apollo Clinics
A core offering of this tie-up is access to Mapmygenome’s flagship genetic assessments, which serve as a comprehensive "health horoscope" for preventative care:
-
Genomepatri: A master health test offering over 100 detailed reports spanning lifestyle diseases, physiological traits, carrier status, and drug responses.
-
Genomepatri Lite: A specialized screening focused strictly on cardiology and oncology, yielding 50 reports that map out heart health, metabolic traits, and risk levels for 15 different types of cancer.
Both genetic assessments are now integrated into this joint initiative to help patients actively evaluate their underlying immunity frameworks and long-term health risks.
